APPLICATION
ANDA210839
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-17
LATEST ACTION
2020-10-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
NOREPINEPHRINE BITARTRATEDiscontinued
NOREPINEPHRINE BITARTRATE EQ 1MG BASE/ML · INJECTABLE · INJECTION
Approval history
2020-10-30Labeling · Supplement 6 · standardAP
2018-12-17UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.